In general, given the high prevalence of NOTCH1 variants among patients with CHD and having identified a specific NOTCH1 DNAm signature, we argue that DNAm analysis can contribute substantially to a more accurate variant assessment, ultimately resulting in improved case management. Here, NOTCH1 is linked to coronary artery disorder.